Pacira Biosciences
PCRX
Pacira Biosciences (PCRX) - Net assets
Net assets on the balance sheet as of December 2023 : $0.87 B
According to Pacira Biosciences
's latest financial reports the company has $0.87 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Pacira Biosciences - Net assets on balance sheet (from 2009 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.87 B | 12.27% |
| 2022-12-31 | $0.77 B | 6.11% |
| 2021-12-31 | $0.73 B | 17.87% |
| 2020-12-31 | $0.61 B | 74.59% |
| 2019-12-31 | $0.35 B | 10.5% |
| 2018-12-31 | $0.32 B | 14.94% |
| 2017-12-31 | $0.27 B | 27.63% |
| 2016-12-31 | $0.21 B | 0.27% |
| 2015-12-31 | $0.21 B | 27.61% |
| 2014-12-31 | $0.17 B | 314.91% |
| 2013-12-31 | $41.24 M | -37.36% |
| 2012-12-31 | $65.85 M | 36.43% |
| 2011-12-31 | $48.26 M | -199.76% |
| 2010-12-31 | $-48.39 M | 110.83% |
| 2009-12-31 | $-22.95 M | -406.4% |
| 2008-12-31 | $7.49 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Omeros Corporation OMER | -$13.96 M | -101.60% | 🇺🇸 USA |
 Heron Therapeutics HRTX | -$33.98 M | -103.90% | 🇺🇸 USA |
 Cara Therapeutics
CARA | $57.08 M | -93.44% | 🇺🇸 USA |